FHTX — Foghorn Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Foghorn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	154	346	234	244	159
Net Total Receivables	300	0	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	460	351	240	250	163
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	56.1	49.4	42.9	32.6	32.9
Other Long Term Assets
Total Assets	520	405	286	284	198
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	48.7	55.2	58.4	67	59.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	423	405	363	330	307
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	96.9	0.112	-77.2	-45.5	-109
Total Liabilities & Shareholders' Equity	520	405	286	284	198
Total Common Shares Outstanding